Bipartisan legislation proposes streamlining FDA biosimilar approvals to expand competition and reduce prescription drug costs.
Quiver AI Summary
Bill introduced: Rep. Nick Langworthy and Rep. Kim Schrier said they introduced the “Expedited Access to Biosimilars Act,” a bipartisan bill aimed at updating FDA biosimilar approval rules and speeding access to lower-cost prescription drugs.
What the bill would do: The measure would say extra clinical studies should not be automatically required when existing evidence is sufficient, while keeping FDA authority to require more data when scientifically needed. It would also require early FDA notice if such studies are expected.
Support cited: The release says the proposal is backed by health providers, patient advocates, employers, insurers, and biosimilar manufacturers, and quotes supporters saying it could expand competition and lower costs.
Disclaimer: This is an AI-generated summary of a press release. The model used to summarize this release may make mistakes. See the full release here.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
Nicholas A. Langworthy Fundraising
Nicholas A. Langworthy recently disclosed $314.1K of fundraising in a Q2 FEC disclosure filed on July 11th, 2026. This was the 13th most from all Q2 reports we have seen this year. 22.7% came from individual donors.
Langworthy disclosed $7.9K of spending. This was the 301st most from all Q2 reports we have seen from politicians so far this year.
Langworthy disclosed $2.5M of cash on hand at the end of the filing period. This was the 15th most from all Q2 reports we have seen this year.
You can see the disclosure here, or track Nicholas A. Langworthy's fundraising on Quiver Quantitative.
Nicholas A. Langworthy Net Worth
Quiver Quantitative estimates that Nicholas A. Langworthy is worth $347.8K, as of July 15th, 2026. This is the 432nd highest net worth in Congress, per our live estimates.
Langworthy has approximately $8.8K invested in publicly traded assets which Quiver is able to track live.
You can track Nicholas A. Langworthy's net worth on Quiver Quantitative's politician page for Langworthy.
Nicholas A. Langworthy Bill Proposals
Here are some bills which have recently been proposed by Nicholas A. Langworthy:
- H.R.9661: To amend the Public Health Service Act to codify that the default expectation for licensure of biological products as biosimilar does not include clinical studies assessing pharmacodynamics or comparative clinical efficacy, and for other purposes.
- H.R.9317: BUSES Act
- H.R.9117: To promote the availability of certain healthcare information, and for other purposes.
- H.R.7941: Pay TSA Act of 2026
- H.R.7502: Recycled Materials Attribution Act of 2026
- H.R.7366: Dietary Supplement Regulatory Uniformity Act
You can track bills proposed by Nicholas A. Langworthy on Quiver Quantitative's politician page for Langworthy.
2026 New York's 23rd Congressional District Election
There has been approximately $16,431,173 of spending in New York's 23rd congressional district elections over the last two years, per our estimates.
The rating for this race is currently "Solid R".
You can track this election on our matchup page for the 2026 New York's 23rd congressional district election.
